首页|大柴胡汤治疗代谢相关性脂肪性肝病的研究进展

大柴胡汤治疗代谢相关性脂肪性肝病的研究进展

Research progress of Dachaihu Decoction in the treatment of metabolic-associated fatty liver disease

扫码查看
代谢相关性脂肪性肝病(MAFLD)已成为全球最常见的慢性肝病,可进展为肝纤维化或肝硬化,严重威胁人民健康,但目前尚无特效药物治疗.据研究报道,中医经典名方大柴胡汤治疗MAFLD效果显著,文章通过对文献总结归纳发现,大柴胡汤治疗MAFLD的机制主要与改善胰岛素抵抗、促进线粒体氧化功能、促进线粒体自噬、调节肠道菌群等有关,从基础方证理论、临床研究及基础研究3个方面对大柴胡汤治疗MAFLD进行论述,旨在为大柴胡汤治疗MAFLD的临床应用提供参考价值.
Metabolic-associated fatty liver disease(MAFLD)has become the most common chronic liver disease in the world,which can progress to liver fibrosis or cirrhosis,seriously threatening people's health,but there is no specific drug treatment yet.According to research reports,the classic Chinese medicine formula Dachaihu Decoction is effective in the treatment of MAFLD.In this paper,we summarize and generalize the literature and find that the mechanism of Dachaihu Decoction in the treatment of MAFLD is mainly related to the improvement of insulin resistance,the promotion of mitochondrial oxidation function,the promotion of mitochondrial autophagy,and the regulation of the intestinal bacterial flora,and so on.This paper discusses the treatment of MAFLD by Dachaihu Decoction from three aspects:basic formula theory,clinical research and basic research,aiming to provide reference value for the clinical application of Dachaihu Decoction in the treatment of MAFLD.

Dachaihu DecoctionMetabolic-associated fatty liver disease(MAFLD)Basic formulaClinical studyInsulin resistanceMitochondrionIntestinal bacterial floraProgress

申会会、晁旭、黄峰

展开 >

陕西中医药大学,咸阳 712000

陕西中医药大学第二附属医院,咸阳 712000

大柴胡汤 代谢相关性脂肪性肝病 基础方证 临床研究 胰岛素抵抗 线粒体 肠道菌群 进展

2024

中华中医药杂志
中华中医药学会

中华中医药杂志

CSTPCD北大核心
影响因子:1.135
ISSN:1673-1727
年,卷(期):2024.39(12)